BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8609043)

  • 1. The relationship between aryl hydrocarbon hydroxylase and polymorphisms of the CYP1A1 gene.
    Kiyohara C; Hirohata T; Inutsuka S
    Jpn J Cancer Res; 1996 Jan; 87(1):18-24. PubMed ID: 8609043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between CYP1A1 aryl hydrocarbon hydroxylase activity and lung cancer in a Japanese population.
    Kiyohara C; Nakanishi Y; Inutsuka S; Takayama K; Hara N; Motohiro A; Tanaka K; Kono S; Hirohata T
    Pharmacogenetics; 1998 Aug; 8(4):315-23. PubMed ID: 9731718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A role of aryl hydrocarbon hydroxylase inducibility in susceptibility to lung carcinogenesis].
    Kiyohara C; Hirohata T
    Nihon Eiseigaku Zasshi; 1994 Feb; 48(6):1027-36. PubMed ID: 8126925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Environmental factors and aryl hydrocarbon hydroxylase activity (CYP1A1 phenotype) in human lymphocytes.
    Kiyohara C; Hirohata T
    J Epidemiol; 1997 Dec; 7(4):244-50. PubMed ID: 9465551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population.
    Nakachi K; Imai K; Hayashi S; Kawajiri K
    Cancer Res; 1993 Jul; 53(13):2994-9. PubMed ID: 8319207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of metabolic polymorphisms in lung carcinogenesis].
    Kiyohara C; Ohno Y
    Nihon Koshu Eisei Zasshi; 1999 Apr; 46(4):241-9. PubMed ID: 10491856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of CYP1A1 gene polymorphism using designed RFLP and distributions of CYP1A1 genotypes in Japanese.
    Oyama T; Mitsudomi T; Kawamoto T; Ogami A; Osaki T; Kodama Y; Yasumoto K
    Int Arch Occup Environ Health; 1995; 67(4):253-6. PubMed ID: 7591186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Point-mutational MspI and Ile-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population.
    Hirvonen A; Husgafvel-Pursiainen K; Karjalainen A; Anttila S; Vainio H
    Cancer Epidemiol Biomarkers Prev; 1992; 1(6):485-9. PubMed ID: 1284589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of aryl hydrocarbon hydroxylase inducibility in cultured human lymphocytes.
    Paigen B; Minowada J; Gurtoo HL; Paigen K; Parker NB; Ward E; Hayner NT; Bross ID; Bock F; Vincent R
    Cancer Res; 1977 Jun; 37(6):1829-37. PubMed ID: 870187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of cigarette smoking and CYP1A1 polymorphisms with adenocarcinoma of the lung by grades of differentiation.
    Nakachi K; Hayashi S; Kawajiri K; Imai K
    Carcinogenesis; 1995 Sep; 16(9):2209-13. PubMed ID: 7554077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The heme-binding region polymorphism of cytochrome P450IA1 (CypIA1), rather than the RsaI polymorphism of IIE1 (CypIIE1), is associated with lung cancer in Rio de Janeiro.
    Hamada GS; Sugimura H; Suzuki I; Nagura K; Kiyokawa E; Iwase T; Tanaka M; Takahashi T; Watanabe S; Kino I
    Cancer Epidemiol Biomarkers Prev; 1995; 4(1):63-7. PubMed ID: 7534543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic control of interindividual variations in the inducibility of aryl hydrocarbon hydroxylase in cultured human lymphocytes.
    Atlas SA; Vesell ES; Nebert DW
    Cancer Res; 1976 Dec; 36(12):4619-30. PubMed ID: 63323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CYP1A1 MspI and exon7 gene polymorphisms and lung cancer risk: an updated meta-analysis and review.
    Zhan P; Wang Q; Qian Q; Wei SZ; Yu LK
    J Exp Clin Cancer Res; 2011 Oct; 30(1):99. PubMed ID: 22014025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aryl hydrocarbon hydroxylase in lymphocytes and lung tissue from lung cancer patients and controls.
    Kärki NT; Pokela R; Nuutinen L; Pelkonen O
    Int J Cancer; 1987 May; 39(5):565-70. PubMed ID: 3570549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms of drug-metabolizing enzymes and lung cancer susceptibility.
    Kawajiri K; Watanabe J; Eguchi H; Hayashi S
    Pharmacogenetics; 1995; 5 Spec No():S70-3. PubMed ID: 7581493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP1A1 gene polymorphism and risk of epithelial ovarian neoplasm.
    Aktas D; Guney I; Alikasifoglu M; Yüce K; Tuncbilek E; Ayhan A
    Gynecol Oncol; 2002 Aug; 86(2):124-8. PubMed ID: 12144816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of aryl hydrocarbon hydroxylase in developing laryngeal cancer among smokers].
    Wu Z
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1991; 26(6):325-7, 381. PubMed ID: 1811685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of aryl hydrocarbon hydroxylase activity in cultured human lymphocytes.
    Suolinna EM; Vänttinen E; Aitio A
    Toxicology; 1982; 24(1):73-84. PubMed ID: 7135405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study.
    Wenzlaff AS; Cote ML; Bock CH; Land SJ; Santer SK; Schwartz DR; Schwartz AG
    Carcinogenesis; 2005 Dec; 26(12):2207-12. PubMed ID: 16051642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquisition of aryl hydrocarbon hydroxylase inducibility by aromatic hydrocarbons in monolayer-cultured hepatocytes from nonresponsive mouse strains.
    Nemoto N; Sakurai J; Tazawa A; Ishikawa T
    Cancer Res; 1990 Jun; 50(11):3226-30. PubMed ID: 1692256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.